David Carr, a New York Times columnist, writes that the real motivation for the calls for details on Steve Jobs’ health is simple voyeurism.
\

But last week, Mr. Jobs returned to work on a part-time basis, precisely when he said he would. Experts with only a general knowledge of his treatment suggest his prognosis is good.
\

\
That did not stop the keening on the blogs, in the news media and in the investment community that he and Apple needed to do a medical full monty to explain his conditions because they believe they are material to the company\’92s future and should be reported as such.
\

\
To which I, and not many others, say: Is anyone really confused about Mr. Jobs\’92s health status? I remain unconvinced, in part because I believe that prurience, not legitimate financial concerns, drives most people\’92s interest in the illness of others.